Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8559
Reference
MSAN(2025)47
Name
Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Mometasone (Asmanex Twisthaler®) 200microgram/dose dry powder inhaler (60 dose) is being discontinued from late October 2025.
Mometasone (Asmanex Twisthaler®) 200microgram/dose dry powder inhaler (30 dose) and 400micrograms/dose dry powder inhaler (30 dose and 60 dose) are being discontinued from late February 2026.
Alternative corticosteroid inhalers remain available (see Additional Information section).
Contact Name
Contact Email
Contact Address
Created
2025-10-27 10:24:00
Click to go back to homepage